In some models, CXCR2 ligands may exhibit anti-angiogenic properties [104], suggesting that in some types of cancer, CXCR2 ligands act as anti-angiogenic agents, whereas in others, they act as pro-angiogenic agents. The gene discussed is CXCR2; the disease is cancer.